Suppression of IL-6 Gene by shRNA Augments Gemcitabine Chemosensitization in Pancreatic Adenocarcinoma Cells
Joint Authors
Wang, Jing
Tong, Mengting
Li, Da
Xing, Hai-Bo
Hu, Hong
Zhai, Chong-Ya
Huang, Chang-Xin
Source
Issue
Vol. 2018, Issue 2018 (31 Dec. 2018), pp.1-10, 10 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2018-03-06
Country of Publication
Egypt
No. of Pages
10
Main Subjects
Abstract EN
Pancreatic adenocarcinoma has an exceedingly poor prognosis, accounting for five-year survival of less than 5%.
Presently, improving the efficacy of pancreatic adenocarcinoma treatment has been the focus of medical researchers worldwide.
Recently, it has been suggested that deregulation of interleukin- (IL-) 6 is caused by a key gene involved in the beginning and development of pancreatic adenocarcinoma.
Herein, we investigated whether suppression of IL-6 could augment gemcitabine sensitivity in the PANC-1 cells.
We found considerably higher expression of IL-6 in pancreatic adenocarcinoma tissues than that in the adjacent nontumorous tissues.
Suppression of IL-6 by shRNA resulted in apoptosis as well as inhibition of cell proliferation and tumorigenicity.
In addition, suppression of IL-6 remarkably promoted antitumor effect of gemcitabine, indicating that the combination of shRNA targeting IL-6 with gemcitabine may provide a potential clinical approach for pancreatic cancer therapy.
American Psychological Association (APA)
Xing, Hai-Bo& Tong, Mengting& Wang, Jing& Hu, Hong& Zhai, Chong-Ya& Huang, Chang-Xin…[et al.]. 2018. Suppression of IL-6 Gene by shRNA Augments Gemcitabine Chemosensitization in Pancreatic Adenocarcinoma Cells. BioMed Research International،Vol. 2018, no. 2018, pp.1-10.
https://search.emarefa.net/detail/BIM-1125699
Modern Language Association (MLA)
Xing, Hai-Bo…[et al.]. Suppression of IL-6 Gene by shRNA Augments Gemcitabine Chemosensitization in Pancreatic Adenocarcinoma Cells. BioMed Research International No. 2018 (2018), pp.1-10.
https://search.emarefa.net/detail/BIM-1125699
American Medical Association (AMA)
Xing, Hai-Bo& Tong, Mengting& Wang, Jing& Hu, Hong& Zhai, Chong-Ya& Huang, Chang-Xin…[et al.]. Suppression of IL-6 Gene by shRNA Augments Gemcitabine Chemosensitization in Pancreatic Adenocarcinoma Cells. BioMed Research International. 2018. Vol. 2018, no. 2018, pp.1-10.
https://search.emarefa.net/detail/BIM-1125699
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1125699